Ascendis Pharma A/S (ASND)
213.18
+3.84
(+1.83%)
USD |
NASDAQ |
Dec 31, 16:00
215.30
+2.12
(+0.99%)
After-Hours: 20:00
Ascendis Pharma Market Cap: 13.02B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 226.04B |
| Evaxion AS | 30.19M |
| DBV Technologies SA | 523.02M |
| Cellectis SA | 487.58M |
| Akari Therapeutics Plc | 10.27M |
Market Cap Related Metrics
| PS Ratio | 17.83 |
| Price | 213.18 |
| Earnings Yield | -1.99% |